Larry Whitfield
Endocrinology, Diabetes & Metabolism · Denison, TXNPI 1558311605
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,598 and has fallen 94.8% since, to $83 in 2022. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in TX, where the typical reported total is $2,974.
Across 134 payments — averaging $14.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$382
- Novo Nordisk$201
- Merck$200
- Insulet Corporation$176
- Corcept Therapeutics$140
- AbbVie$136
- plus $749 from 14 others
What the payments were for
- Food & beverage$1,97299%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 20 | $382 |
| Novo Nordisk | 21 | $201 |
| Merck | 17 | $200 |
| Insulet Corporation | 10 | $176 |
| Corcept Therapeutics | 10 | $140 |
| AbbVie | 9 | $136 |
| Amgen | 10 | $132 |
| Lilly USA, LLC | 7 | $95 |
| Shire North American Group Inc | 4 | $78 |
| Abbott | 4 | $73 |
| Sanofi-aventis U.S. LLC | 4 | $59 |
| Boehringer Ingelheim | 3 | $58 |
| Johnson & Johnson | 3 | $51 |
| Radius Health, Inc. | 3 | $43 |
| Pfizer | 2 | $35 |
| IBSA Pharma Inc. | 2 | $31 |
| Medtronic | 2 | $29 |
| Dexcom, Inc. | 1 | $27 |
| Amarin Pharma, Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
How this compares
$1,984 in reported general payments places this provider in the 40th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.
See all endocrinology, diabetes & metabolism providers in Texas →
Other endocrinology, diabetes & metabolism in Denison
- Lance SloanLufkin$1.7M
- Pablo MoraDallas$1.3M
- Robert HoodBeaumont$1.3M
- Eduardo LunaEdinburg$1.3M
- Steve FordanDallas$1.2M
- Rosemarie LajaraPlano$1.2M
- Saleemah FahmiDallas$1.2M
- Julio RosenstockDallas$1.2M
- Rocio HarbisonHouston$989K
- Mitchell SorsbyPlano$945K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.